Results 81 to 90 of about 3,817,010 (199)

Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity

open access: yesFrontiers in Cell and Developmental Biology, 2020
COVID-19, a novel coronavirus pneumonia (named by the World Health Organization, WHO), has spread widely since the end of 2019. Research on synthetic drugs and vaccines has become a focus of attention in China and other countries, as such approaches are ...
Jin Zhou, Jie Huang, Jie Huang
doaj   +1 more source

SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT This study examined changes in anti‐Spike (anti‐S) antibodies (Abs) and type I interferon (IFN‐I) following the BNT162b2 vaccine in people living with HIV (PLWH) and analyzed the impact of demographic and immunological factors. In total, 75 PLWH and 28 healthy donors were followed at baseline (T0), at the second dose (T1), after the second ...
Federica Frasca   +18 more
wiley   +1 more source

Características clínicas, de laboratorio y radiológicas de pacientes pediátricos hospitalizados con COVID-19: serie de casos

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2020
De toda la población infectada por el SARS-CoV-2, la población pediátrica representa del 1 al 5%, siendo un reto caracterizarla clínicamente. Presentamos cinco casos de pacientes pediátricos con diagnóstico de COVID-19; el rango de edad fue de 1 a 14 ...
Héctor Nuñez-Paucar   +7 more
doaj   +1 more source

Enhanced Immunogenicity and Cross‐Neutralizing Activity of a Trivalent Adenoviral Vector‐Based SARS‐CoV‐2 Vaccine in Mice

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT The emergence of diverse SARS‐CoV‐2 Omicron subvariants has reduced the efficacy of existing vaccines, highlighting the need for multivalent vaccines with broader neutralizing capacity. We developed a trivalent adenoviral vector‐based vaccine (Ad5‐CoV19‐prototype/Delta/BF.7) encoding the spike proteins of the ancestral strain, Delta variant ...
Jianhua Li   +7 more
wiley   +1 more source

Potentially highly potent drugs for 2019-nCoV [PDF]

open access: yes, 2020
Abstract The World Health Organization (WHO) has declared the 2019 novel coronavirus (2019-nCoV) infection outbreak a global health emergency. Currently, there is no effective anti-2019-nCoV medication. The sequence identity of the 3CL proteases of 2019-nCoV and SARS is 96%, which provides a sound foundation for structural-based drug ...
Nguyen, Duc Duy   +4 more
openaire   +2 more sources

Promising Inhibitor for 2019-nCoV in Drug Development

open access: yes, 2020
The 2019 novel coronavirus (2019-nCoV), which is first detected in Wuhan, China, is a virus identified as the cause of pneumonia. In the event of epidemic outbreak, a series of actions have taken by the Chinese government to control the pandemic of the ...
Zilong Dang, Xiaohui Xu
core   +1 more source

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

open access: yesEmerging Microbes and Infections, 2020
A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health ...
Jasper Fuk-Woo Chan   +6 more
doaj   +1 more source

Viral Infection‐Inspired Autonomous Detection of Fusion‐Competent Viruses for Screening and Environmental Surveillance

open access: yesAdvanced Materials, Volume 38, Issue 40, 17 July 2026.
Inspired by viral entry mechanisms, the FUSION assay enables autonomous detection of respiratory viruses via membrane fusion–triggered CRISPR‐Cas13a activation. VEACON selectively fuses with fusion‐competent viruses, triggering fluorescence within confined vesicles.
Jae Chul Park   +15 more
wiley   +1 more source

Structure analysis of the receptor binding of 2019-nCoV

open access: yesBiochemical and Biophysical Research Communications, 2020
2019-nCoV is a newly identified coronavirus with high similarity to SARS-CoV. We performed a structural analysis of the receptor binding domain (RBD) of spike glycoprotein responsible for entry of coronaviruses into host cells. The RBDs from the two viruses share 72% identity in amino acid sequences, and molecular simulation reveals highly similar ...
Chen, Yun   +3 more
openaire   +2 more sources

Sensitive and Spatially‐Resolved Electrochemiluminescence via Micropatterning

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 13, 7 July 2026.
The use of a simple silica nanoparticle surface coating and patterning process can transform ordinary gold electrodes into multiplexed ECL sensing electrodes. Through spatially confined droplet formation and local ECL emission, it is possible to perform multiple analyses simultaneously from individual locations as well as intensify the ECL signal by as
Yuliang Shao   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy